Misoprostol 200Mcg Tab
DrugMisoprostol 200 mcg dissolvedwith 200 ml water and divided to 25ml solution every 2 hours per os for maximum of 8 doses
NCT Number: NCT06056141
Comparison of efficacy and safety of low-dose oral Misoprostol versus folley catheter for preinduction in women with an immature cervix at term.
Looking for future studies?
Notify Me18 year–49 year
Female
Interventional
Phase 4
Center for Perinatology and Pediatric Cardiac Surgery, Almaty, Kazakhstan
Open-label randomised trial in 2 hospitals in the Almaty,Kazakhstan. Women with a term singleton pregnancy in cephalic presentation, an unfavourable cervix, intact membranes, and without a previous caesarean section will be randomly allocated to 2 groups: 1 group -cervical ripening with 25 μg oral misoprostol once every 2 hour, 2 nd group- a 30 mL transcervical Foley catheter. The primary outcome will be vaginal delivery within 24 hours(to evaluate effectiveness) and secondary outcoms 1-5-min Apgar score and hospitalization in ICU, hyperstimulation frequency and hemorrage (for evaluating safety)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Misoprostol 200 mcg dissolvedwith 200 ml water and divided to 25ml solution every 2 hours per os for maximum of 8 doses
Transcervical Foley catheter (silicone, size 20F with 30ml balloon)
Time frame: 24 hours.
Number of Participants with vaginal births within 24 hours.
Time frame: 5 min
Rate of cases Apgar score <7 points
Time frame: during the labour induction
incidence of hyperstimulation
Kazakhstan's Medical University "KSPH"
Other
Induction of Labour at Term With Low Dose Oral Misoprostol Versus a Foley Catheter: a Multicentre Randomised Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04955847
Cesarean Section, Induction of Labor
Amiens, France
View Trial DetailsNCT07503184
Dexamethasone, Female Urogenital Diseases and Pregnancy Complications
Multan, Punjab Province, Pakistan
View Trial DetailsNCT07261332
Female Urogenital Diseases and Pregnancy Complications, Fetal Membranes, Premature Rupture
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT02477085
Induction of Labor
Paris, France
View Trial Details